Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...

The US Food and Drug Administration (FDA) has approved Medtronic's Symplicity Spyral renal denervation system for the treatment of hypertension, the company has announced. The Symplicity Spyral system ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

For the first time in its history, the U.S. Renal Data System Annual Data Report included a chapter devoted to home dialysis, offering an unprecedented view of the evolution of home therapies during ...

The US Food and Drug Administration has approved the Symplicity Spyral renal denervation system despite the lack of an endorsement from one of its advisory committees, bringing a second such ...

The kidneys contain millions of microscopic blood vessels known as peritubular capillaries. These vessels recapture helpful nutrients like glucose and minerals and return them to your bloodstream for ...

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first-in-human cases ...